|
""Mechanisms of diet-induced, estrogen-independent mammary growth""
|
1F31CA189421-01
|
$34,541
|
$34,541
|
BERRYHILL, GRACE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
(PQA-2) Reprogramming of circulating adipose stromal cells by mechanical stress
|
1R21CA184084-01
|
$193,160
|
$193,160
|
LI, RONG
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise
|
5R01CA179963-02
|
$514,066
|
$514,066
|
BRYAN, ANGELA
|
UNIVERSITY OF COLORADO
|
|
(PQA1) Regulation of Metformin Response by Breast Cancer Associated Gene 2 (BCA2)
|
1R21CA184788-01
|
$198,360
|
$198,360
|
DOU, QING PING
|
WAYNE STATE UNIVERSITY
|
|
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
|
5R01CA180033-02
|
$286,214
|
$286,214
|
MISKIMINS, W
|
SANFORD RESEARCH/USD
|
|
(PQA1)Toward understanding mechanisms of COX-2 driven metastasis of breast cancer
|
1R21CA185226-01
|
$202,221
|
$202,221
|
LYONS, TRACI
|
UNIVERSITY OF COLORADO DENVER
|
|
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival
|
1R01CA184953-01
|
$629,652
|
$629,652
|
CAAN, BETTE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
|
1R01CA185293-01
|
$345,696
|
$345,696
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
|
5R01CA180070-02
|
$345,551
|
$345,551
|
HEBER-KATZ, ELLEN
|
WISTAR INSTITUTE
|
|
(PQA2) Reversing Carcinogenic Effect of Obesity on Basal-like Breast Cancer
|
5R21CA180134-02
|
$154,570
|
$154,570
|
HAYES, LIZA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
(PQA2): Escape from breast tumor dormancy: convergence of obesity and menopause
|
1R01CA185530-01
|
$364,336
|
$364,336
|
MOSES, MARSHA
|
CHILDREN'S HOSPITAL CORPORATION
|
|
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk
|
5R01CA179977-02
|
$715,557
|
$357,779
|
KERR, JACQUELINE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
(PQB-3) Characterization of the immune response during mammary tumor initiation
|
1R21CA184541-01
|
$165,300
|
$165,300
|
SCHWERTFEGER, KATHRYN
|
UNIVERSITY OF MINNESOTA
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
1R01CA184572-01
|
$329,925
|
$108,875
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
(PQC2)Nanoscale changes in 3D nuclear architecture during breast tumorigenesis
|
1R01CA185363-01
|
$317,738
|
$317,738
|
LIU, YANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQC3) Essential Role of BCL9 in Promotion of Human DCIS to Invasive Ductal Carci
|
1R21CA185460-01
|
$197,055
|
$197,055
|
BEHBOD, FARIBA
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
|
1R01CA185138-01
|
$486,312
|
$486,312
|
HWANG, EUN-SIL
|
DUKE UNIVERSITY
|
|
(PQC4) Fate of cells disseminating from human breast cancer xenografts
|
5R01CA180039-02
|
$318,015
|
$318,015
|
WERB, ZENA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQC4) Towards In Vivo, 3D Cytotyping By Stimulated Raman Spectroscopic Imaging-
|
1R21CA190120-01
|
$205,353
|
$61,606
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
(PQC5 in RFA-CA-12-020) Using MR phase to detect ferritin tagged breast cancer ce
|
1R21CA184682-01
|
$198,360
|
$198,360
|
HU, JIANI
|
WAYNE STATE UNIVERSITY
|
|
(PQC6) Molecular Determinants of Quiescent Cancer Cells
|
1R01CA185086-01
|
$446,131
|
$446,131
|
RAMASWAMY, SRIDHAR
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD3) Genetic Basis of Breast Cancer Resistance in BRCA1+ Carrier
|
5R21CA180008-02
|
$189,050
|
$189,050
|
WANG, SAN MING
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
|
1R21CA185000-01
|
$221,954
|
$221,954
|
GIMELBRANT, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
(PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS
|
3R01CA180061-02S1
|
$111,758
|
$111,758
|
WOODWARD, WENDY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS
|
5R01CA180061-02
|
$393,713
|
$393,713
|
WOODWARD, WENDY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care
|
1R01CA190016-01
|
$729,945
|
$729,945
|
NATTINGER, ANN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$274,403
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
2014 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA186413-01
|
$2,500
|
$825
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
|
5K99CA172357-02
|
$94,829
|
$94,829
|
NELSON, ERIK
|
DUKE UNIVERSITY
|
|
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
|
4R00CA172357-03
|
$241,148
|
$241,148
|
NELSON, ERIK
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
3-D Computer Modeling for Optimizing Body Image following Breast Reconstruction
|
5R01CA143190-05
|
$525,834
|
$525,834
|
MARKEY, MIA
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
3D Photoacoustic Tomography (PAT)and Dynamic Contrast-Enhanced PAT Breast Imaging
|
5R01CA160850-03
|
$640,051
|
$640,051
|
KRUGER, ROBERT
|
OPTOSONICS, INC.
|
|
4D Microfluidic Platforms for Targeting Breast Cancer:Lymphatic Interactions
|
5R21CA175931-02
|
$160,342
|
$160,342
|
SLOANE, BONNIE
|
WAYNE STATE UNIVERSITY
|
|
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
|
5R01CA169182-03
|
$319,383
|
$319,383
|
GANESAN, SHRIDAR
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
|
1R01CA174929-01A1
|
$678,168
|
$678,168
|
PARK, CATHERINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A comprehensive approach to breast cancer susceptibility across the risk spectrum
|
5R01CA155767-04
|
$573,230
|
$573,230
|
GOLDGAR, DAVID
|
UNIVERSITY OF UTAH
|
|
A Cyber-Informatics Approach to Studying Migration and Environmental Cancer Risk
|
5R01CA170508-03
|
$380,613
|
$190,307
|
TOURASSI, GEORGIA
|
UT-BATTELLE, LLC-OAK RIDGE NATIONAL LAB
|
|
A FEASIBILITY PET STUDY OF HER2 RECEPTORS IN BREAST CANCER USING 89ZR-TRASTUZUMAB
|
1R21CA182945-01
|
$315,400
|
$315,400
|
DEHDASHTI, FARROKH
|
WASHINGTON UNIVERSITY
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-03
|
$1,262,499
|
$252,500
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans
|
5U01CA158428-03
|
$284,046
|
$142,023
|
BUCKHAULTS, PHILLIP
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
A Geospatial Investigation of Breast Cancer Treatment
|
1R15CA179355-01A1
|
$425,800
|
$425,800
|
ADAMS, SWANN
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-05
|
$339,713
|
$84,928
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Model for Individualized Risk Prediction of Contralateral Breast Cancer
|
1R21CA186086-01
|
$237,132
|
$237,132
|
BISWAS, SWATI
|
UNIVERSITY OF TEXAS DALLAS
|
|
A nanosystem for tumor treatment and imaging
|
1R01CA188883-01A1
|
$404,625
|
$404,625
|
RUOSLAHTI, ERKKI
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention
|
5R01CA164166-02
|
$308,358
|
$308,358
|
MACLEAN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
A Novel Allele-Specific RNA-ISH for Differential Allele-specific Expression
|
1R21CA186853-01
|
$232,943
|
$232,943
|
CHEN, XIAOWEI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
|
1R01CA181115-01A1
|
$369,640
|
$369,640
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A NOVEL EXTRACELLULAR AND INTRACELLULAR TREATMENT PARADIGM FOR ERADICATING CANCER
|
1F30CA189435-01
|
$29,179
|
$29,179
|
SOM, AVIK
|
WASHINGTON UNIVERSITY
|
|
A Novel Function for G6PD in Regulation of the Cancer Epigenome
|
1R03CA188592-01
|
$77,000
|
$77,000
|
VOGELAUER, MARIA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel IgE Cancer Therapeutic Specific for the Epithelial Membrane Protein-2
|
5R21CA179680-02
|
$194,941
|
$64,331
|
DANIELS-WELLS, TRACY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Total relevant funding to Breast for this search: $528,546,755
|